Literature DB >> 21143513

Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking.

S A Walsh1, D Creamer.   

Abstract

Summary Drug reaction with eosinophilia and systemic symptoms (DRESS) describes a severe medication-induced adverse reaction, which has cutaneous, haematological and solid-organ features. It is one of the triad of life-threatening drug hypersensitivity dermatoses, along with acute generalized exanthematous pustulosis (AGEP) and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). In this article, we discuss several controversies that surround DRESS, including problems with nomenclature and the lack of consensus in diagnostic criteria. © The Author(s). CED
© 2010 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2011        PMID: 21143513     DOI: 10.1111/j.1365-2230.2010.03967.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  49 in total

Review 1.  Leflunomide-induced DRESS syndrome with renal involvement and vasculitis.

Authors:  Benzeeta Pinto; Varun Dhir; Sabari Krishnan; Ritambhra Nada
Journal:  Clin Rheumatol       Date:  2012-12-28       Impact factor: 2.980

Review 2.  Human herpesviruses 6, 7, and 8 from a dermatologic perspective.

Authors:  Michael M Wolz; Gabriel F Sciallis; Mark R Pittelkow
Journal:  Mayo Clin Proc       Date:  2012-07-21       Impact factor: 7.616

Review 3.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.

Authors:  Peter Valent; Gerald J Gleich; Andreas Reiter; Florence Roufosse; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Karl Sotlar; Joseph H Butterfield; Sabine Cerny-Reiterer; Matthias Mayerhofer; Peter Vandenberghe; Torsten Haferlach; Bruce S Bochner; Jason Gotlib; Hans-Peter Horny; Hans-Uwe Simon; Amy D Klion
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

Review 4.  Drug Hypersensitivity.

Authors:  Ruwen Böhm; Ehrhardt Proksch; Thomas Schwarz; Ingolf Cascorbi
Journal:  Dtsch Arztebl Int       Date:  2018-07-23       Impact factor: 5.594

5.  Highly Probable Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Lenalidomide.

Authors:  Anusha Shanbhag; E Ryan Pritchard; Kshitij Chatterjee; Drayton A Hammond
Journal:  Hosp Pharm       Date:  2017-07-18

Review 6.  Severe cutaneous adverse drug reactions.

Authors:  Rajesh Verma; Biju Vasudevan; Vijendran Pragasam
Journal:  Med J Armed Forces India       Date:  2013-03-17

7.  Sulfasalazine-induced DRESS and severe agranulocytosis successfully treated by granulocyte colony-stimulating factor.

Authors:  Neila Fathallah; Raoudha Slim; Salaheddine Rached; Wissem Hachfi; Amel Letaief; Chaker Ben Salem
Journal:  Int J Clin Pharm       Date:  2015-04-09

8.  DRESS syndrome presenting after initiation of mycobacterium avium complex osteomyelitis treatment.

Authors:  Paul W Blair; Douglas Herrin; Nawaf Abaalkhail; Wesley Fiser
Journal:  BMJ Case Rep       Date:  2015-10-05

9.  DRESS syndrome and thrombotic thrombocytopaenic purpura: are they related?

Authors:  Zahrae Sandouk; Zaid Alirhayim; Dania Khoulani; Syed Hassan
Journal:  BMJ Case Rep       Date:  2012-11-14

10.  Testing for drug hypersensitivity syndromes.

Authors:  Craig M Rive; Jack Bourke; Elizabeth J Phillips
Journal:  Clin Biochem Rev       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.